SEBI Debarred Entities

The SEBI debarred entities list includes individuals and organizations that have been prohibited by the securities and exchange board of India (SEBI) from participating in securities markets. This action is typically taken due to violations of regulatory guidelines or laws related to securities trading and investment.

Mitigate risk with our comprehensive screening solutions for your AML and sanctions compliance.
11,559 Entities in SEBI Debarred Entities
Entity NameEntity TypeEffective DateStatus

Spnj land project and developers india limited

CompanyMay 16, 2016inactive

Spnj land project and developers india limited

CompanyMay 16, 2016active

Parivar dairies and allied ltd

CompanyOct 10, 2017active

Sankeshwara credit and investments limited

CompanyAug 24, 2022active

Investment research advisor sebi registration no ina000003387 proprietor amit gangrade

CompanyApr 26, 2023inactive

Chankya apparels pvt ltd

CompanyNov 12, 2018inactive

D r softech industries limited

CompanyDec 13, 2010inactive

Shukan enterprise

CompanyApr 29, 2022active

Eros worldwide fz llc

CompanyJun 22, 2023active

Goldensight commotrade pvt ltd

CompanySep 4, 2023active

FAQs

Why is compliance with the Sanctioned Providers by The Defense Health Agency of United States (DHA) necessary?

Compliance with the Sanctioned Providers List published by the Defense Health Agency (DHA) is crucial for maintaining the integrity and security of healthcare services. These sanctions are implemented to protect beneficiaries from entities that may engage in fraudulent or unsafe practices. Adherence ensures that healthcare providers are not only meeting legal and regulatory standards but also safeguarding public health. Failing to comply can result in serious legal implications, financial penalties, and a diminished quality of care for those who rely on DHA services.

Which companies should comply with Sanctioned Providers by The Defense Health Agency of United States (DHA)?

The Sanctioned Providers List by the Defense Health Agency (DHA) primarily impacts healthcare organizations, including hospitals, clinics, and pharmaceutical companies. These entities must comply to ensure they do not engage with individuals or organizations that pose risks to patient safety or violate federal regulations. Compliance protects public health and maintains the integrity of the healthcare system while avoiding legal repercussions.